Business · 02/02/2016Updated: 10/17/2026 · 1 min read
FDA Seeks Public Comment on Proposed Collection of Patent Information for New Drug Applications
Summary
The Food and Drug Administration (FDA) is requesting public input on proposed changes to its reporting requirements for patent information related to new drug applications, with a 60-day comment period set to begin.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →